Management of Hepatocellular Carcinoma in Japan as a World-Leading Model
- PMID: 29888204
- PMCID: PMC5985410
- DOI: 10.1159/000484619
Management of Hepatocellular Carcinoma in Japan as a World-Leading Model
Figures
References
-
- Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology. 1983;148:397–401. - PubMed
-
- Kudo M, Vera DR, Trudeau WL, Stadalnik RC. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model. J Nucl Med. 1991;32:1177–1182. - PubMed
-
- Kudo M, Todo A, Ikekubo K, Yamamoto K, Vera DR, Stadalnik RC. Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin. Hepatology. 1993;17:814–819. - PubMed
-
- Honjo I, Araki C. Total resection of the right lobe of the liver; report of a successful case. J Int Coll Surg. 1955;23:23–28. - PubMed
-
- Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet. 1985;161:346–350. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
